Manning & Napier Advisors LLC Buys 6,430 Shares of Humana Inc. (NYSE:HUM)

Manning & Napier Advisors LLC lifted its position in Humana Inc. (NYSE:HUM - Free Report) by 92.4% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,387 shares of the insurance provider's stock after buying an additional 6,430 shares during the period. Manning & Napier Advisors LLC's holdings in Humana were worth $3,542,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. raised its position in shares of Humana by 15.8% during the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after purchasing an additional 1,751,857 shares during the period. Dodge & Cox raised its position in shares of Humana by 106.7% during the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock worth $2,587,345,000 after purchasing an additional 5,264,045 shares during the period. Pzena Investment Management LLC raised its position in shares of Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after purchasing an additional 1,103,132 shares during the period. Geode Capital Management LLC raised its position in shares of Humana by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock worth $729,658,000 after purchasing an additional 63,562 shares during the period. Finally, Invesco Ltd. raised its position in shares of Humana by 29.8% during the fourth quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock worth $608,348,000 after purchasing an additional 550,692 shares during the period. Institutional investors own 92.38% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. Truist Financial set a $280.00 target price on Humana and gave the stock a "hold" rating in a research report on Tuesday, June 17th. Mizuho boosted their target price on Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Raymond James Financial raised Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price on the stock in a research report on Thursday, May 1st. Guggenheim assumed coverage on Humana in a research report on Wednesday, April 9th. They set a "buy" rating and a $326.00 target price on the stock. Finally, Barclays set a $268.00 target price on Humana and gave the stock an "equal weight" rating in a research report on Thursday, June 12th. Seventeen analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $280.76.

Humana Stock Down 2.0%

HUM stock traded down $4.81 during mid-day trading on Monday, hitting $234.81. The stock had a trading volume of 1,806,791 shares, compared to its average volume of 1,813,548. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.71. Humana Inc. has a 1-year low of $212.45 and a 1-year high of $406.46. The company has a fifty day moving average of $244.77 and a 200 day moving average of $260.35. The stock has a market capitalization of $28.34 billion, a price-to-earnings ratio of 16.61, a PEG ratio of 1.81 and a beta of 0.43.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping the consensus estimate of $10.07 by $1.51. Humana had a return on equity of 14.47% and a net margin of 1.42%. The company had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. During the same period in the prior year, the firm posted $7.23 EPS. The business's revenue was up 8.4% compared to the same quarter last year. On average, equities analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.51%. The ex-dividend date of this dividend is Friday, June 27th. Humana's payout ratio is 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.